The invention discloses traditional Chinese pharmaceutical composition for curing cardiovascular and cerebrovascular diseases. The traditional Chinese pharmaceutical composition is prepared from the following raw materials in parts by weight: 5-10 parts of radix fici simplicissimae, 10-15 parts of cortex eucommiae, 7-12 parts of caulis polygoni multiflori, 15-20 parts of folium
ginkgo, 3-7 parts of herba catharanthi rosei, 13-18 parts of radix et rhizoma
salvia miltiorrhizae, 7-12 parts of radix notoginseng, 7-12 parts of
emblica officinalis fruit, 10-15 parts of folium ilicis chinensis, 7-12 parts of herba pyrolae, 10-15 parts of radix puerariae lobatae, 14-18 parts of fiveleaf
gynostemma herb and 7-10 parts of corn stigma. The invention also discloses a preparation method of the traditional Chinese pharmaceutical composition. According to the traditional Chinese pharmaceutical composition, the folium
ginkgo and the radix et rhizoma
salvia miltiorrhizae are utilized as monarch
drug, and other traditional Chinese medicines are utilized as auxiliary materials; thus, dialectical compatibility and synergistic interaction are achieved,
cholesterol, blood glucose and blood fat are effectively reduced, blood vessels are softened, atherosclerosis of the blood vessels is prevented and cured, thrombogenesis is prevented, and
blood circulation and body
immunity function are enhanced. Furthermore, the traditional Chinese pharmaceutical composition has a good curing effect on the cardiovascular and cerebrovascular diseases and is small in
side effect and obvious in treatment course.